Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-04 @ 1:48 PM
Study NCT ID:
NCT02163356
Status:
TERMINATED
Last Update Posted:
2022-03-31
First Post:
2014-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Sponsor:
South Plains Oncology Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-27
First Submit QC Date:
None
Study First Post Date:
2014-06-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-17
Last Update Post Date:
2022-03-31
Last Update Post Date Type:
ACTUAL